Triple-negative breast cancer (TNBC) is a subset of breast cancer without the expression of estrogen receptor (ER) and progesterone receptor (PgR) and without the overexpression or gene amplification of human epidermal growth factor receptor 2 (HER2) [1]. Here, ESR1 is linked to triple-negative breast carcinoma.